Evidence map›Paper›PMID 32957612›Full record

ArticleMolecules (Basel, Switzerland)2020

Effect of Daily Intake of Green Tea Catechins on Cognitive Function in Middle-Aged and Older Subjects: A Randomized, Placebo-Controlled Study.

Yoshitake Baba, Shun Inagaki, Sae Nakagawa, Toshiyuki Kaneko, Makaoto Kobayashi, Takanobu Takihara

Registry-linked trialAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06604390 (THE EFFECTS OF GAMBIR CATECHIN), which is not on this map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06604390 nacompletednot on this mapstarted 2024, after this paper: background citation

The effects of gambir catechin (uncaria gambir roxb) supplementation on cognitive function, expression of amyloid precursor protein (app), microtubule associated protein tau (mapt), brain-derived neurotrophic factor (bdnf), interleukin 10 (il-10), transforming growth factor-beta (tgf-beta), and plasma malondialdehyde (mda) levels in the elderly

TypeinterventionalSponsorRahmi Novita YusufRan2024 to 2024Enrolled64ConditionsElderly Individuals Aged 60 Years or Older, Mild Cognitive Impairment (MCI)Armscatechin extracts (health food), plasebo
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yoshitake BabaCentral Research Institute, ITO EN, Ltd., 21 Mekami, Makinohara, Shizuoka 421-0516, Japan.
Shun InagakiCentral Research Institute, ITO EN, Ltd., 21 Mekami, Makinohara, Shizuoka 421-0516, Japan.
Sae NakagawaCentral Research Institute, ITO EN, Ltd., 21 Mekami, Makinohara, Shizuoka 421-0516, Japan.
Toshiyuki KanekoTokyo Skytree Station Medical Clinic, Ryobi Building F4 33-13 Mukojima 3-chome, Sumida-ku, Tokyo 131-0033, Japan.
Makaoto KobayashiCentral Research Institute, ITO EN, Ltd., 21 Mekami, Makinohara, Shizuoka 421-0516, Japan.
Takanobu TakiharaCentral Research Institute, ITO EN, Ltd., 21 Mekami, Makinohara, Shizuoka 421-0516, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidemiological studies in Japan, including the Nakajima study and the Tsurugaya study, have indicated that green tea consumption may improve cognitive impairment. Catechins, which are typical polyphenols contained in green tea, have been reported to have antioxidative, anti-inflammatory, and neuroprotective effects. However, their impact on human cognitive function remains unclear. Therefore, we performed a double-blind, randomized, controlled study to investigate the effect of 336.4 mg of decaffeinated green tea catechins (GTC) on cognitive function after a single dose and after 12 weeks of daily intake. This study included Japanese adults between the ages of 50 and 69 years with a Mini-Mental State Examination Japanese version score of >24 and self-assessed cognitive decline. The Cognitrax testing battery was used to evaluate cognitive function. The incorrect response rate on the Continuous Performance Test significantly decreased after a single dose of GTC. After 12 weeks of daily GTC intake, the response time for Part 4 of the 4-part Continuous Performance Test, which is a two-back test, was shortened. These results suggest that daily intake of GTC might have beneficial effects on working memory.

Indexed as

Administration, OralAmyloidAnti-Inflammatory AgentsAntioxidantsBiomarkersCatechinCognitionCognitive DysfunctionDietary SupplementsDouble-Blind MethodFemaleHumansJapanMaleMiddle AgedNeuroprotective AgentsAmyloidAnti-Inflammatory AgentsAntioxidantsBiomarkersCatechinNeuroprotective AgentsPolyphenolsTeacatechinscognitive functionCognitraxgreen teamiddle-agedrandomized placebo-controlled trial

Identifiers

PMID32957612
PMCPMC7570631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.